Titlebook: Antiviral Strategies; Hans-Georg Kr?usslich,Ralf Bartenschlager Book 2009 Springer-Verlag Berlin Heidelberg 2009 Antiviral Drug.DNA.Drug R

eternal

書目名稱Antiviral Strategies影響因子(影響力)




書目名稱Antiviral Strategies影響因子(影響力)學(xué)科排名




書目名稱Antiviral Strategies網(wǎng)絡(luò)公開度




書目名稱Antiviral Strategies網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Antiviral Strategies被引頻次




書目名稱Antiviral Strategies被引頻次學(xué)科排名




書目名稱Antiviral Strategies年度引用




書目名稱Antiviral Strategies年度引用學(xué)科排名




書目名稱Antiviral Strategies讀者反饋




書目名稱Antiviral Strategies讀者反饋學(xué)科排名

IRATE

非實體

諂媚于人

Viral Protease Inhibitors,hese have made the most significant advances in the recent past. Thus, we discuss the biochemistry of HIV-1 protease, inhibitor development, clinical use of inhibitors, and evolution of resistance. Since many different viruses encode essential proteases, it is possible to envision the development of

妨礙

Anti-Influenza Drugs: The Development of Sialidase Inhibitors, annum as a result of viral infections alone. The scourge of influenza virus has plagued mankind throughout the ages. The fact that new viral strains emerge on a regular basis, particularly out of Asia, establishes a continual socio-economic threat to mankind. The arrival of the highly pathogenic av

解開

angina-pectoris

Inhibitors of Viral Entry,rs exert their biological properties by inhibiting protein—protein interactions either within the viral envelope (Env) glycoproteins or between viral Env and host-cell receptors. The nature of resistance to entry inhibitors also differs from compounds inhibiting enzymatic targets due to their differ

車床

Interferons and Their Use in Persistent Viral Infections,ned, fully sequenced and IFN-α was produced in recombinant form. Recombinant IFN-α is now used as the basis for treatment of chronic hepatitis C virus infection and can also be used to treat certain forms of chronic hepatitis B virus infections. IFNs have also been used in other viral infections, al

青石板

Nucleic Acids-Based Therapeutics in the Battle Against Pathogenic Viruses,nse oligonucleotides, ribozymes, DNAzymes, and aptamers can be designed to trigger the sequence-specific inhibition of particular mRNA transcripts, including viral genomes. However, difficulties with their efficiency, off-target effects, toxicity, delivery, and stability halted the development of nu

陶器